RESEARCH TRIANGLE PARK – Two life science companies that each announced they would open offices in the Triangle within the last 12 months today announced a partnership between the two firms.
Worldwide Clinical Trials, which moved its headquarters to the RTP Frontier last January, will collaborate with Science 37, which announced it would move headquarters to Morrisville in December after the company went public through a completion of a business combination with a special purpose acquisition company (SPAC) in October.
According to a statement, Worldwide Clinical Trials “will leverage Science 37’s Operating System—bringing biopharmaceutical sponsors an end-to-end technology platform and specialized networks solutions for faster and more patient-centric clinical trial execution.”
The deal puts Worldwide Clinical Trials on the list of the Science 37 CRO Certified network, the statement noted.
“Working with Worldwide strengthens our ability to enable universal access to patients and providers and brings our Operating System to more sponsors for faster enrollment, greater retention, and a more representative patient population,” said Steve Geffon, Chief Commercial Officer of Science 37, in the statement. “Our technology platform and specialized networks of patient communities, telemedicine investigators, mobile nurses, and remote coordinators enables Worldwide to provide more decentralization clinical trial capability for agile clinical trial designs that support patients and accelerate the development of treatments that impact people’s lives.”